---
title: "MREO.US (MREO.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MREO.US/news.md"
symbol: "MREO.US"
name: "MREO.US"
parent: "https://longbridge.com/en/quote/MREO.US.md"
datetime: "2026-05-19T21:43:54.479Z"
locales:
  - [en](https://longbridge.com/en/quote/MREO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MREO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MREO.US/news.md)
---

# MREO.US (MREO.US) — Related News

### [Cantor Fitzgerald Remains a Buy on Mereo Biopharma Group Plc (MREO)](https://longbridge.com/en/news/286558931.md)
*2026-05-15T11:37:25.000Z*
> Cantor Fitzgerald has maintained a Buy rating on Mereo Biopharma Group Plc (MREO) with a price target of $3.00, while th

### [Mereo BioPharma Shareholders Approve All AGM Resolutions](https://longbridge.com/en/news/286435474.md)
*2026-05-14T14:49:02.000Z*
> Mereo BioPharma Group plc held its 2026 Annual General Meeting on May 14, 2026, where shareholders approved all resoluti

### [European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading](https://longbridge.com/en/news/286287063.md)
*2026-05-13T15:12:00.000Z*
> European equities traded in the US as American depositary receipts saw a slight increase of 0.08% to 1,829.64 on the S&P

### [Mereo Biopharma | 10-Q: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286095656.md)
*2026-05-12T12:05:22.000Z*
### [Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates](https://longbridge.com/en/news/286092727.md)
*2026-05-12T11:31:16.000Z*
> London-based Mereo BioPharma Group plc (NASDAQ: MREO) revealed its financial performance for the first quarter ending Ma

### [European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading](https://longbridge.com/en/news/285966449.md)
*2026-05-11T15:05:00.000Z*
> European equities traded in the US as American depositary receipts opened the week flat, edging up 0.08% to 1,835.34 on 

### [16:59 ETMREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit](https://longbridge.com/en/news/281718188.md)
*2026-04-05T21:00:43.000Z*
> Rosen Law Firm is reminding investors who purchased American Depositary Shares of Mereo BioPharma Group plc (NASDAQ: MRE